PainDETECT as a Potential Tool for Personalized Medicine: Predicting Outcome One Year After Knee Arthroplasty.
Wall AJW. et al, (2025), Mayo Clin Proc Innov Qual Outcomes, 9
Brain signatures of nociplastic pain: Fibromyalgia Index and descending modulation at population level.
Kelleher EM. et al, (2025), Brain
Systematic review and co-ordinate based meta-analysis to summarize the utilization of functional brain imaging in conjunction with human models of peripheral and central sensitization.
Clarke S. et al, (2024), Eur J Pain, 28, 1069 - 1094
CENTRALISED PAIN IN EARLY RHEUMATOID ARTHRITIS PREDICTS WORSE BODILY PAIN OUTCOMES
Kelleher E. et al, (2024), RHEUMATOLOGY, 63, I74 - I74
THE USE OF ONLINE PLATFORMS IN THE TREATMENT OF CHRONIC MUSCULOSKELETAL DISEASE
Wall AJW. et al, (2024), RHEUMATOLOGY, 63, I146 - I146
Hippocampus mediates nocebo impairment of opioid analgesia through changes in functional connectivity.
Bingel U. et al, (2022), Eur J Neurosci, 56, 3967 - 3978
IMI2-PainCare-BioPain-RCT1: study protocol for a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by peripheral nerve excitability testing (NET).
Nochi Z. et al, (2022), Trials, 23
IMI2-PainCare-BioPain-RCT3: a randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects to investigate the effects of lacosamide, pregabalin, and tapentadol on biomarkers of pain processing observed by electroencephalography (EEG).
Mouraux A. et al, (2021), Trials, 22
"Consensus on Placebo and Nocebo Effects Connects Science with Practice:" Reply to "Questioning the Consensus on Placebo and Nocebo Effects".
Evers AWM. et al, (2021), Psychother Psychosom, 90, 213 - 214
What Should Clinicians Tell Patients about Placebo and Nocebo Effects? Practical Considerations Based on Expert Consensus.
Evers AWM. et al, (2021), Psychother Psychosom, 90, 49 - 56
Opioids for breathlessness: psychological and neural factors influencing response variability.
Abdallah SJ. et al, (2019), Eur Respir J, 54
Response to "Treating patients rather than their functional neuroimages" (Br J Anaesth 2018; 121: 969-71).
Wanigasekera V. et al, (2019), Br J Anaesth, 123, e166 - e171
Central Sensitization in Knee Osteoarthritis: Relating Presurgical Brainstem Neuroimaging and PainDETECT-Based Patient Stratification to Arthroplasty Outcome.
Soni A. et al, (2019), Arthritis Rheumatol, 71, 550 - 560
Sertraline or placebo in chronic breathlessness? Lessons from placebo research.
Pattinson K. and Wanigasekera V., (2019), Eur Respir J, 53
Disambiguating pharmacological mechanisms from placebo in neuropathic pain using functional neuroimaging.
Wanigasekera V. et al, (2018), Br J Anaesth, 120, 299 - 307
Opioid suppression of conditioned anticipatory brain responses to breathlessness.
Hayen A. et al, (2017), Neuroimage, 150, 383 - 394
Opioids decrease the unpleasantness of dyspnoea via actions in the medial prefrontal cortex
Hayen A. et al, (2017), BIOLOGICAL PSYCHOLOGY, 129, 375 - 376